August 10, 2017
Until recently, CRISPR-Cas9 gene editing could only be used to manipulate DNA. In 2016, University of California San Diego School of Medicine researchers repurposed the technique to track RNA in live cells in a method called RNA-targeting Cas9. In a study published August 10 in Cell, the team took RCas9…
August 19, 2024
…provided that comforting and familiar space for thousands of patients, medical students, physicians and volunteers.
July 30, 2020
Researchers at UC San Diego School of Medicine and Moores Cancer Center report that an investigational drug candidate called tipifarnib showed promise in treating key recurring mutation in head and neck cancers.
February 15, 2024
Gyamfi-Bannerman is the first UC San Diego faculty member to serve as president of the leading medical society working toward equitable pregnancy outcomes.
May 31, 2015
Accurately assessing pain in children in a clinical setting can be difficult. A study by researchers at the University of California, San Diego School of Medicine has demonstrated the validity of a new method for measuring pediatric pain levels using novel facial pattern recognition software.
March 22, 2021
Zea Borok, MD, has been named chair of the Department of Medicine at University of California San Diego School of Medicine. Her first day is April 1, 2021.
October 21, 2024
University of California San Diego School of Medicine researchers find advanced AI could lead to easier, faster and more efficient hospital quality reporting.
August 25, 2021
Stem cell models derived from people with specific genomic variation recapitulate aspects of their autism spectrum disorder, providing a valuable model to study the condition and look for therapeutic interventions.
March 8, 2018
…their commitment to diversity, equity and inclusion 2017 Equal Opportunity/Affirmative Action and Diversity Awardees: Executive Vice Chancellor and Vice Chancellor Area Recipients Academic Affairs: Chandler E. Puritty Advancement: Danielle Dawson, JD, MBA Chancellor’s Office: Jaime A. Lopez-Miramontes Chief Financial Officer: Yvonne R. Hernandez Friedman Equity, Diversity, and Inclusion: Matthew T.…
May 2, 2016
Oncternal Therapeutics, a new cancer-focused biotechnology startup, has signed a wide-ranging licensing agreement with UC San Diego to develop and commercialize antibodies and antibody-related binding agents.
